Hernia Repair Devices Market Size, Share, and Trends 2024 to 2034

The global hernia repair devices market size is estimated at USD 5.37 billion in 2024, grew to USD 5.64 billion in 2025 and is predicted to hit around USD 8.80 billion by 2034, expanding at a CAGR of 5.07% between 2024 and 2034. The North America hernia repair devices market size accounted for USD 2.74 billion in 2024 and is anticipated to grow at a fastest CAGR of 5.14% during the forecast year.

  • Last Updated : November 2024
  • Report Code : 2572
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Hernia Repair Devices Market 

5.1. COVID-19 Landscape: Hernia Repair Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Hernia Repair Devices Market, By Product Type

8.1. Hernia Repair Devices Market, by Product Type, 2024-2034

8.1.1 Hernia Mesh

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Hernia Fixation Devices

8.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Hernia Repair Devices Market, By Surgery Type

9.1. Hernia Repair Devices Market, by Surgery Type, 2024-2034

9.1.1. Inguinal Hernia

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Umbilical Hernia

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Incisional Hernia

9.1.3.1. Market Revenue and Forecast (2021-2034)

9.1.4. Femoral Hernia

9.1.4.1. Market Revenue and Forecast (2021-2034)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Hernia Repair Devices Market, By Procedure Type 

10.1. Hernia Repair Devices Market, by Procedure Type, 2024-2034

10.1.1. Open Surgery

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Laparoscopic Surgery

10.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Hernia Repair Devices Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product Type (2021-2034)

11.1.2. Market Revenue and Forecast, by Surgery Type (2021-2034)

11.1.3. Market Revenue and Forecast, by Procedure Type (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product Type (2021-2034)

11.1.4.2. Market Revenue and Forecast, by Surgery Type (2021-2034)

11.1.4.3. Market Revenue and Forecast, by Procedure Type (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product Type (2021-2034)

11.1.5.2. Market Revenue and Forecast, by Surgery Type (2021-2034)

11.1.5.3. Market Revenue and Forecast, by Procedure Type (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product Type (2021-2034)

11.2.2. Market Revenue and Forecast, by Surgery Type (2021-2034)

11.2.3. Market Revenue and Forecast, by Procedure Type (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product Type (2021-2034)

11.2.4.2. Market Revenue and Forecast, by Surgery Type (2021-2034)

11.2.4.3. Market Revenue and Forecast, by Procedure Type (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product Type (2021-2034)

11.2.5.2. Market Revenue and Forecast, by Surgery Type (2021-2034)

11.2.5.3. Market Revenue and Forecast, by Procedure Type (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product Type (2021-2034)

11.2.6.2. Market Revenue and Forecast, by Surgery Type (2021-2034)

11.2.6.3. Market Revenue and Forecast, by Procedure Type (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product Type (2021-2034)

11.2.7.2. Market Revenue and Forecast, by Surgery Type (2021-2034)

11.2.7.3. Market Revenue and Forecast, by Procedure Type (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product Type (2021-2034)

11.3.2. Market Revenue and Forecast, by Surgery Type (2021-2034)

11.3.3. Market Revenue and Forecast, by Procedure Type (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product Type (2021-2034)

11.3.4.2. Market Revenue and Forecast, by Surgery Type (2021-2034)

11.3.4.3. Market Revenue and Forecast, by Procedure Type (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product Type (2021-2034)

11.3.5.2. Market Revenue and Forecast, by Surgery Type (2021-2034)

11.3.5.3. Market Revenue and Forecast, by Procedure Type (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product Type (2021-2034)

11.3.6.2. Market Revenue and Forecast, by Surgery Type (2021-2034)

11.3.6.3. Market Revenue and Forecast, by Procedure Type (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product Type (2021-2034)

11.3.7.2. Market Revenue and Forecast, by Surgery Type (2021-2034)

11.3.7.3. Market Revenue and Forecast, by Procedure Type (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product Type (2021-2034)

11.4.2. Market Revenue and Forecast, by Surgery Type (2021-2034)

11.4.3. Market Revenue and Forecast, by Procedure Type (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product Type (2021-2034)

11.4.4.2. Market Revenue and Forecast, by Surgery Type (2021-2034)

11.4.4.3. Market Revenue and Forecast, by Procedure Type (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product Type (2021-2034)

11.4.5.2. Market Revenue and Forecast, by Surgery Type (2021-2034)

11.4.5.3. Market Revenue and Forecast, by Procedure Type (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product Type (2021-2034)

11.4.6.2. Market Revenue and Forecast, by Surgery Type (2021-2034)

11.4.6.3. Market Revenue and Forecast, by Procedure Type (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product Type (2021-2034)

11.4.7.2. Market Revenue and Forecast, by Surgery Type (2021-2034)

11.4.7.3. Market Revenue and Forecast, by Procedure Type (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product Type (2021-2034)

11.5.2. Market Revenue and Forecast, by Surgery Type (2021-2034)

11.5.3. Market Revenue and Forecast, by Procedure Type (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product Type (2021-2034)

11.5.4.2. Market Revenue and Forecast, by Surgery Type (2021-2034)

11.5.4.3. Market Revenue and Forecast, by Procedure Type (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product Type (2021-2034)

11.5.5.2. Market Revenue and Forecast, by Surgery Type (2021-2034)

11.5.5.3. Market Revenue and Forecast, by Procedure Type (2021-2034)

Chapter 12. Company Profiles

12.1. B Braun Melsungen AG

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Cook Medical

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Medtronic Plc

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. W.L. Gore & Associates

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Ethicon Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. C.R Bard Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Atrium

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. LifeCell Corporation

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Baxter International

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Hernia mesh S.R.L.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client